Massachusetts is talking with
drug companies such as Eli Lilly & Co. about accepting grants for
“disease management” programs to reduce the state’s cost for
Medicaid, the Boston Globe said.
Drug companies such as Eli Lilly and Pfizer Inc. have offered
similar programs, which assign nurses to Medicaid patients who
require expensive treatments, in other states such as Colorado and
Florida in return for getting their drugs on a list of approved
medications for Medicaid, the Globe said.
Rhode Island's Market Has Changed. Developers, Builders, Investors and Sellers Must Change With It.
By Emilio DiSpirito IV License Partner | Engel & Völkers Oceanside Leader | The DiSpirito…
Learn More
Massachusetts, which faces a $3.2 billion shortfall in its
budget next year, has seen expenses in its Medicaid program
increase 13 percent annually over the past two years, the Globe
said.
Eli Lilly spokeswoman Tarra Ryker and the medical director of
Massachusetts’ Medicaid program, Dr. Annette Hanson, both told the
paper that the state and the drug company are in talks. They would
not disclose the amount under consideration, the paper said.
Bloomberg News
